▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3809 by analyst upside · 2026-11-14
MCK
McKesson Corporation
Healthcare · Market Cap $127B · P/E 28.4x
ANALYST PRICE TARGET
+3.8%
implied upside to consensus target
Current Price $1102.81
Consensus Target $1144.29
Bull Target $1260.0
Bear Target $965.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
9
Hold
3
Sell
0
52-Week Low $723.68
52-Week High $1121.5
YTD Return +34.3%
FUNDAMENTALS
Market Cap $127B
P/E Ratio (TTM) 28.4x
Forward P/E 21.1x
EPS (TTM) $38.77
PEG Ratio 1.86
Dividend Yield 0.35%
Revenue (TTM) $418.8B
Profit Margin 1.1%
52-WEEK RANGE
52-Week Low $723.68
52-Week High $1121.5
Current Price $1102.81
Bear Target $965.0
Bull Target $1260.0
● Now $1102.81 ● Target $1144.29
TRADING DATA
Avg Volume 804K
YTD Return +34.3%
Analyst Count 14
Consensus Buy
Upside to Target +3.8%
Last Updated 2026-11-14

ANALYST SUMMARY

McKesson Corporation (MCK) is currently trading at $1102.81 with a Wall Street consensus price target of $1144.29, implying potential upside of 3.8% over the next 12 months. 14 analysts currently cover MCK, with a consensus rating of Buy - 80% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1260.0, while the most cautious has a target of $965.0.

MCK operates in the Healthcare sector with a market capitalisation of $127B. The stock is up 34.3% year-to-date and is currently trading near the upper end of its 52-week range of $723.68 – $1121.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MCK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Mizuho - Reiterated
Neutral → Neutral 2026-10-20 Building track record
UBS - Reiterated
Buy → Buy 2026-10-16 33% win rate (6 calls)
Leerink Partners - Reiterated
Outperform → Outperform 2026-10-07 29% win rate (7 calls)
RBC Capital reit
Sector Perform → Sector Perform 2026-09-14 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-08-19 Building track record
RBC Capital ● Initiated
Sector Perform 2026-08-19 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-08-11 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-08-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
68
out of 100
Coverage depth
21/30
Consensus clarity
25/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →